AllDocs -> cancers

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:5cIhd4QuvGIJ:static.cjp.com/gems/blood/Iida.pdf allintitle: myeloma filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States Linda Morris Brown 1, *, Gloria Gridley 1 , Linda M. Pottern 2,a , Dalsu Baris 1 , Christine A. Swanson 2,b , Debra T. Silverman 1 , Richard B. Hayes 1 , Raymond S. Greenberg 3,c , G. Marie Swanson 4,d , Janet B. Schoenberg 5 , Ann G. Schwartz 4 & Joseph F. Fraumeni, Jr 1 1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Executive Plaza South, Room 8026, 6120 Executive Blvd. MSC 7244, Bethesda, MD 20892-7244, USA; 2 National Cancer Institute, Bethesda MD, USA; 3 Rollins School of Public Health, Emory University, Atlanta, GA, USA; ...

Cancer Mortality Rates by State Economic Area (Age-adjusted 1970 US Population) Multiple Myeloma : Black Males, 1970-94 US = 6.49/100,000 8.84-20.58 (highest 10%) 7.83- 8.83 7.47- 7.82 7.13- 7.46 6.86- 7.12 6.40- 6.85 5.98- 6.39 5.68- 5.97 5.19- 5.67 3.25- 5.18 (lowest 10%) Sparse data (292 SEAs; 5.00% of deaths)

THE ECONOMIC IMPACTS OF THE MYELOMA INSTITUTE FOR RESEARCH AND THERAPY ACTIVITIES ON THE STATE OF ARKANSAS Dennis P. Robinson, Ph.D. Institute for Economic Advancement University of Arkansas at Little Rock April 4, 2003 This report provides an analysis of the economic impacts of activities at the Myeloma Institute for Research and Therapy on the economy of the state of Arkansas. Report Highlights • The Institute raises almost $2 million per year in philanthropy dollars. • Over the past 14 years, the Institute has brought in over $30 million in out-of- state research grants. • The Institute employs roughly 285 people performing clinical care, research, and administrative functions. • In one year, over 1,600 patients come to the Institute. Very few of these are Little Rock residents. On average, 1.07 people ...

myeloma MULTIPLE MYELOMA ADVOCACY Please sign up to help when needed. These volunteer organizations e-mail you brief information when a need arises. You decide whether or not you wish to support each particular issue, so there is no real commitment on your part. You are given precise instructions and even provided the e-mails to send and the details one where to send them. It is very easy! STATE LEVEL (TX): ACS Grassroots Volunteers The American Cancer Society calls their program Legislative Alert. They distribute issues from the Texas legislature to concerned individuals for help with advocacy (lobbying). Your involvement is only requested about 2 or 3 times a year, and it is so easy for you to do something that really does help make a difference. Please consider helping! For sign-up, the website is http://www.cancer.org or contact Sarah ...

MULTIPLE MYELOMA IN THE RAILROAD INDUSTRY __ R. Dean Hartley Hartley & O'Brien 827 Main Street Wheeling, West Virginia 26003 (304) 233-0777 Telephone (304) 233-0774 Telecopier HNOLAW@HGO.NET I. INTRODUCTION. The word " myeloma " means a tumor of the bone marrow. Most people develop many bone marrow tumors, hence the name "multiple myeloma ." Multiple myeloma is a neoplasm of mature and immature plasma cells. 1 These plasma cells characteristically cause destruction of bone, leading to such troublesome complications as bone pain, compression, fractures, hypercalcemia and renal damage. 2 Abnormal radiographs of the skeleton are found in 80 percent or more of patients at diagnosis. Multiple punched-out osteolytic lesions involving the red bone marrow are typical. 3 Complete remission is rare, and a possible cure has been reported ...

Bangkok, Thailand October 24–28, 1999 162 Conventional Chemotherapy for Multiple Myeloma Robert A. Kyle Minimal criteria for the diagnosis of multiple myeloma con- sists of more than 10% plasma cells in the bone marrow or a plasmacytoma and one of the following: 1) M-protein in the serum (usually > 3g/dL); 2) M-protein in the urine; or 3) lytic bone lesions. These findings must not be related to metastatic carcinoma, lymphoma, connective tissues disor- ders, or chronic infections. It is also necessary that the pa- tient have the usual clinical features of multiple myeloma . Monoclonal gammopathy of undetermined significance (MGUS) (1) , smoldering multiple myeloma (SMM) (2) and pri- mary systemic amyloidosis (AL) (3) must be included in the differential diagnosis. The size of the M-protein in the se- rum and ...

Proteasome inhibitors disrupt the unfolded protein response in myeloma cells Ann-Hwee Lee*, Neal N. Iwakoshi*, Kenneth C. Anderson †‡ , and Laurie H. Glimcher* †§ *Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115-6017; † Department of Medicine, Harvard Medical School, Boston, MA 02115; and ‡ Jerome Lipper Multiple Myeloma Center, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA 02115 This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected on April 30, 2002. Contributed by Laurie H. Glimcher, June 30, 2003 Novel agents that target the proteasome, a proteolytic complex responsible for the degradation of ubiquitinated proteins, have demonstrated remarkable therapeutic efficacy in multiple my- eloma, ...

M ul ti ple myeloma is a clonal B-cell ma lig nancy usu ally seen in the el derly, with the me dium age at the time of di ag no sis be ing in the 7 th de cade of life. Its in ci dence among young in di vid u als was low (0.18% & 0.3%, re spec tively, in two large ret ro spec tive se ries). 1,2 The dis ease usu ally in volves bone mar row and bone. Al - though extramedullary plasmacytomas are not un usual, ce re bral plasmacytoma is rarely doc u mented. Young pa - tients (be low 30 years of age) seem to have more fa vor - able prog no sis and better sur vival. 2,3 We here with de - scribe a young pa tient of clin i cally ag gres sive myeloma with un usual man i fes ta tion and re view the lit er a ture. CASE RE PORT A 28-year-old man was ad mit ted to a gen eral hos pi - tal in June, 1999 be cause of se vere left knee joint ...